drugset / Trial / NCT00203112

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

NCT00203112

Phase 2 Completed 44 enrolled Teva Branded Pharmaceutical Products R&D, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study investigates the add-on effect of oral minocycline in subjects treated with daily injection of Copaxone. Copaxone and minocycline are thought to have differential modes of actions that may complement each other in treating MS symptoms.

Timeline

Start
2004-06
Primary completion
2006-06
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minocycline Small molecule 100 mg Oral
Background Glatiramer Acetate Small molecule 20 mg Subcutaneous